Yago Nieto

Yago Nieto

UNVERIFIED PROFILE

Are you Yago Nieto?   Register this Author

Register author
Yago Nieto

Yago Nieto

Publications by authors named "Yago Nieto"

Are you Yago Nieto?   Register this Author

100Publications

4137Reads

48Profile Views

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia.

Biol Blood Marrow Transplant 2019 03 9;25(3):505-514. Epub 2018 Oct 9.

Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, University of Texas, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183059
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.032DOI Listing
March 2019

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

Eur J Haematol 2017 Dec 8;99(6):532-535. Epub 2017 Oct 8.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12970DOI Listing
December 2017

The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells.

Leuk Lymphoma 2017 11 10;58(11):2705-2716. Epub 2017 Apr 10.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1306647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526721PMC
November 2017

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease.

Am J Surg Pathol 2017 Nov;41(11):1483-1490

Departments of *Stem Cell Transplantation and Cellular Therapy †Pathology ‡Gastroenterology, The University of Texas M.D. Anderson Cancer Center §Department of Pediatric Oncology, Baylor College of Medicine, Houston, TX ∥Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000914DOI Listing
November 2017

Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Expert Opin Drug Metab Toxicol 2017 Sep 17;13(9):901-923. Epub 2017 Aug 17.

b Department of Stem Cell Transplantation , The University of Texas M.D. Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2017.1360277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584057PMC
September 2017

Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Aug 20;23(8):1276-1281. Epub 2017 Apr 20.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.04.013DOI Listing
August 2017

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2017 Jul 4;23(7):1059-1063. Epub 2017 Apr 4.

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.03.030DOI Listing
July 2017

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

Eur J Haematol 2017 Mar 1;98(3):263-268. Epub 2016 Dec 1.

Department of Stem Cell Transplantation and Cellular therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12826DOI Listing
March 2017

Stem cell transplantation outcomes in lymphoblastic lymphoma.

Leuk Lymphoma 2017 02 27;58(2):366-371. Epub 2016 Jun 27.

a Department of Stem Cell Transplantation and Cellular Therapy , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1193860DOI Listing
February 2017

Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells.

Leuk Lymphoma 2016 11 16;57(11):2644-52. Epub 2016 Mar 16.

b Department of Stem Cell Transplantation and Cellular Therapy , UT MD Anderson Cancer Center , Houston , TX , USA ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2016.1157871DOI Listing
November 2016

Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.

Leuk Res 2016 08 27;47:100-8. Epub 2016 May 27.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2016.05.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961533PMC
August 2016

Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.

J Med Case Rep 2016 Jul 28;10:209. Epub 2016 Jul 28.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13256-016-0999-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964004PMC
July 2016

Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study.

Exp Hematol 2016 06 11;44(6):458-65. Epub 2016 Mar 11.

Department of Stem Cell Transplantation & Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2016.03.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864055PMC
June 2016

Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.

Biol Blood Marrow Transplant 2016 May 29;22(5):843-9. Epub 2015 Dec 29.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703203PMC
May 2016

Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.

Am J Surg Pathol 2016 May;40(5):676-88

Departments of *Hematopathology †Stem Cell Transplantation §Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX #Biostatistics **Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston ¶Department of Pathology, UT Southwestern Medical Center, Dallas, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ∥Department of Pathology, University of Miami, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000614DOI Listing
May 2016

Isolated renal mucormycosis in a transplantation recipient.

J Clin Oncol 2015 Apr 12;33(10):e50-1. Epub 2014 May 12.

The University of Texas MD Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.1969DOI Listing
April 2015

Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for acute myeloid leukemia.

J Natl Compr Canc Netw 2014 Dec;12(12):1660-4; quiz 1664

From the Division of Cancer Medicine, Department of Infectious Disease, and Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0167DOI Listing
December 2014

The emerging role of gemcitabine in conditioning regimens for hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2014 Sep 9;20(9):1382-9. Epub 2014 May 9.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140026
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2014.04.025DOI Listing
September 2014

Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2013 Jul 30;19(7):1059-64. Epub 2013 Apr 30.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.04.014DOI Listing
July 2013

Transplantation for refractory germ cell tumors: does it really make a difference?

Authors:
Yago Nieto

Curr Oncol Rep 2013 Jun;15(3):232-8

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 423, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-013-0309-5
Publisher Site
http://dx.doi.org/10.1007/s11912-013-0309-5DOI Listing
June 2013

Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines.

Exp Hematol 2012 Oct 9;40(10):800-10. Epub 2012 Jun 9.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447105PMC
October 2012

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation.

J Cancer 2012 8;3:369-80. Epub 2012 Sep 8.

1. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX; ; 7. Current Address: National Cancer Institute, Klenova 1, 833 10 Bratislava, Slovak Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.5111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471078PMC
October 2012

High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?

Biol Blood Marrow Transplant 2012 Jan 4;18(1):3-5. Epub 2011 Dec 4.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.10.045DOI Listing
January 2012